Skip to main content
. 2022 Sep 26;12(4):4161–4169. doi: 10.1002/cam4.5277

FIGURE 1.

FIGURE 1

Trail profile at the cutoff date for analysis. Fifty‐seven patients were assessed and 49 patients were enrolled. Forty‐seven patients were included in the survival analysis and two patients were excluded because they did not receive an efficacy evaluation.